CELZAR 1000MG ING

About

Gemcitabine is a potent nucleoside analog antimetabolite widely employed in the treatment of various solid tumors. Its cytotoxic action stems from its ability to mimic deoxycytidine, a natural DNA building block. After intracellular phosphorylation, gemcitabine inhibits DNA synthesis through two primary mechanisms: it competitively inhibits DNA polymerase, thereby preventing DNA strand elongation, and it incorporates into DNA, leading to chain termination and subsequent DNA damage. This dual mechanism makes it highly effective against rapidly proliferating cancer cells. Gemcitabine is a key therapeutic agent in pancreatic cancer, non-small cell lung cancer, breast cancer, and ovarian cancer, frequently used in combination with other chemotherapeutic agents. Administered intravenously, it is generally known for a relatively manageable toxicity profile, contributing to improved patient outcomes in these challenging malignancies.

Uses

• Pancreatic Cancer
• Non-Small Cell Lung Cancer
• Breast Cancer
• Ovarian Cancer

Directions For Use

Administer intravenously by a healthcare professional over 30 minutes.

Benefits

• Effective against various solid tumors
• Improves survival in pancreatic cancer
• Often used in combination chemotherapy
• Relatively well-tolerated
• Induces tumor regression
• Can be used in metastatic settings

Side Effects

• Myelosuppression (neutropenia, thrombocytopenia, anemia)
• Nausea
• Vomiting
• Flu-like symptoms (fever, headache, myalgia)
• Rash
• Peripheral edema
• Dyspnea
• Elevated liver enzymes
• Proteinuria
• Hemolytic Uremic Syndrome (HUS) (rare)
• Renal failure (rare)
• Hair loss (alopecia)

Safety Measures

• Alcohol - No specific interaction, but avoid excessive alcohol due to potential for exacerbating general malaise or liver stress.
• Pregnancy - Contraindicated due to potential for fetal harm; effective contraception is essential.
• Breastfeeding - Not recommended; discontinue breastfeeding during treatment.
• Liver - Use with caution in patients with hepatic impairment; monitor liver function closely.
• Kidney - Use with caution in patients with renal impairment; monitor renal function closely.
• Lung - Monitor for pulmonary symptoms (e.g., dyspnea, cough) as severe pulmonary toxicity, including ARDS, has been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.